lyra logo.jpg
Lyra Therapeutics Announces Pamela Nelson as Senior Vice President of Regulatory Affairs
August 04, 2020 08:00 ET | Lyra Therapeutics
WATERTOWN, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated...
lyra logo.jpg
Lyra Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference
July 30, 2020 16:05 ET | Lyra Therapeutics
WATERTOWN, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated...
lyra logo.jpg
Lyra Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update
July 24, 2020 08:30 ET | Lyra Therapeutics
WATERTOWN, Mass., July 24, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated...
Equillium_Square_Logo.png
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
July 13, 2020 03:30 ET | Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...
lyra logo.jpg
Lyra Therapeutics Announces Robert Richard, Ph.D., as Senior Vice President of Research and Development
July 07, 2020 08:30 ET | Lyra Therapeutics
WATERTOWN, Mass., July 07, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated...
lyra logo.jpg
Lyra Therapeutics Set to Join the Russell 2000® Index and Russell 3000® Index
June 25, 2020 08:00 ET | Lyra Therapeutics
WATERTOWN, Mass., June 25, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated...
lyra logo.jpg
Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 28, 2020 16:05 ET | Lyra Therapeutics
WATERTOWN, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated...
energias.jpg
Advancement in Sinusitis Surgery Driving the Growth of Sinusitis Treatment Market, to Grow at a CAGR of 12.4% during 2018–2024
October 12, 2018 07:02 ET | Energias Market Research
NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Global Sinusitis Treatment Market size is expected to reach, USD 50.41 Billion in 2024, at a CAGR of 12.4% from 2018 to 2024. Factors propelling the...
Inntopia keeps big year going with on-premises installation capabilities and upgraded conference
April 17, 2018 08:15 ET | Inntopia
Stowe, Vermont , April 17, 2018 (GLOBE NEWSWIRE) -- On the heels of going live with some of the largest clients in the company’s history, Inntopia announced this week a handful of new features...
Inntopia Partners with Angel Fire Resort
October 12, 2016 14:00 ET | Inntopia
Stowe, Vermont - , Oct. 12, 2016 (GLOBE NEWSWIRE) -- Angel Fire Resort is the latest destination resort to partner with Inntopia, the travel industry’s leading e-commerce and central reservation...